Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? (Q38667456)

5 September 2017

title

Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? (English)

1 reference

5 September 2017

0 references

1 reference

Maria Schubert

1

1 reference

5 September 2017

Kerstin Junker

series ordinal

2

1 reference

5 September 2017

Joana Heinzelmann

series ordinal

3

1 reference

5 September 2017

publication date

12 December 2015

1 reference

Journal of Cancer Research and Clinical Oncology

5 September 2017

published in

1 reference

5 September 2017

volume

142

1 reference

5 September 2017

issue

8

1 reference

5 September 2017

page(s)

1673-1695

1 reference

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Plasma microRNA profiles for bladder cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Changes in circulating microRNA levels associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Exosomes/microvesicles as a mechanism of cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Distinct microRNA alterations characterize high- and low-grade bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Accurate molecular classification of renal tumors using microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNAs in cancer: biomarkers, functions and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Molecular pathogenesis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of miR-30d as a novel prognostic maker of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

The epidemiology of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Detection of cancer with serum miRNAs on an oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of docetaxel resistance genes in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Downregulation and prognostic performance of microRNA 224 expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Publication of tumor marker research results: the necessity for complete and transparent reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Widespread deregulation of microRNA expression in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Delivering the promise of miRNA cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA profiling of human kidney cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Predicting progression of bladder urothelial carcinoma using microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

miR-210 is a prognostic marker in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Circulating microRNAs predict biochemical recurrence in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

The microRNA profile of prostate carcinoma obtained by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Global cancer statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

A molecular correlate to the Gleason grading system for prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Comprehensive microRNA Profiling of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Gene networks and microRNAs implicated in aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Expression of microRNAs in the urine of patients with bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

The MicroRNA Spectrum in 12 Body Fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Radical prostatectomy versus observation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

MiR‐96 and miR‐183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Accurate molecular classification of kidney cancer subtypes using microRNA signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

A systematic experimental evaluation of microRNA markers of human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Up-regulation of microRNA-21 correlates with lower kidney cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00432-015-2089-9

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

21 January 2018

1 reference

12 December 2020

Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival

1 reference

12 December 2020

Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy

1 reference

12 December 2020

Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients

1 reference

12 December 2020

The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer

1 reference

12 December 2020

Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

1 reference

12 December 2020

Estimates of cancer incidence and mortality in Europe in 1995

1 reference

12 December 2020

The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma

1 reference

12 December 2020

Circulating miRNAs are correlated with tumor progression in prostate cancer

1 reference

12 December 2020

Rules of evidence for cancer molecular-marker discovery and validation

1 reference

12 December 2020

Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer

1 reference

12 December 2020

Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods

1 reference

12 December 2020

10.1007/S00432-015-2089-9

Identifiers

DOI

1 reference

5 September 2017

1 reference